Pregnant women who are overweight or obese are at least 10 times more likely than women of normal weight to have their fetal ultrasound screening recalled due to poor results, according to Canadian researchers.
Pregnant women who are overweight or obese are at least 10 times more likely than women of normal weight to have their fetal ultrasound screening recalled due to poor results, according to Canadian researchers.
Dr. Phyllis Glanc and colleagues at the University of Toronto assessed 100 women with a body mass index >30 who underwent routine second trimester fetal anatomic survey. They matched each case with two control subjects of normal weight and similar gestational age. They found 72% of pregnant women with high BMI had incomplete or unsatisfactory exams and about 26% required additional ultrasound scans to complete their surveys versus 2.5% of controls. Almost two-thirds of recalled exams remained categorized as having suboptimal visualization. Glanc presented the study at the 2008 ARRS meeting.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.
FDA Clears Ultrasound AI Detection for Pleural Effusion and Consolidation
June 18th 2025The 14th FDA-cleared AI software embedded in the Exo Iris ultrasound device reportedly enables automated detection of key pulmonary findings that may facilitate detection of pneumonia and tuberculosis in seconds.